Literature DB >> 16778634

Multimodal imaging analysis of tumor progression and bone resorption in a murine cancer model.

Maria L Mouchess1, Yasuyoshi Sohara, Marvin D Nelson, Yves A DeCLerck, Rex A Moats.   

Abstract

OBJECTIVE: This study evaluates the use of multimodal imaging to qualitatively and quantitatively measure tumor progression and bone resorption in a xenotransplanted tumor model of human neuroblastoma.
METHODS: Human neuroblastoma cells expressing a luciferase reporter gene were injected into the femur of nu/nu mice. Tumor progression with and without zoledronic acid treatment was monitored using radiographs, D-luciferin-induced luminescence, micro-computer tomography (CT) and micro-magnetic resonance imaging (MRI).
RESULTS: We observed a gradual increase in D-luciferin-based bioluminescence concomitant with detectable osteolytic lesions. Tumor growth was inhibited (P=0.003-0.07) with zoledronic acid treatment. Micro-CT analysis in vivo provided a method to quantify bone loss, and its prevention by zoledronic acid. High-resolution MRI images allowed the observation of tumor cells within the bone marrow cavity, as well as distant metastasis.
CONCLUSION: Multimodal imaging allows to measure tumor growth and bone resorption simultaneously in vivo and also proved useful in the detection distant metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16778634     DOI: 10.1097/00004728-200605000-00030

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  11 in total

1.  In vivo fluorescence imaging of the reticuloendothelial system using quantum dots in combination with bioluminescent tumour monitoring.

Authors:  Yusuke Inoue; Kiyoko Izawa; Kohki Yoshikawa; Haruyasu Yamada; Arinobu Tojo; Kuni Ohtomo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-21       Impact factor: 9.236

Review 2.  Non-invasive molecular imaging for preclinical cancer therapeutic development.

Authors:  A C O'Farrell; S D Shnyder; G Marston; P L Coletta; J H Gill
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

3.  Application of ex vivo micro-computed tomography for assessment of in vivo fluorescence and plain radiographic imaging for monitoring bone metastases and osteolytic lesions.

Authors:  Sanjay Tiwari; Christian Schem; Ann-Christin Lorenzen; Ole Kayser; Claas Wiese; Christian Graeff; Jaime Peña; Robert P Marshall; Martin Heller; Holger Kalthoff; Walter Jonat; Claus-C Glüer
Journal:  J Bone Miner Metab       Date:  2011-12-02       Impact factor: 2.626

4.  Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide.

Authors:  Jennifer E Sprague; Hideki Kitaura; Wei Zou; Yunpeng Ye; Samuel Achilefu; Katherine N Weilbaecher; Steven L Teitelbaum; Carolyn J Anderson
Journal:  J Nucl Med       Date:  2007-02       Impact factor: 10.057

5.  Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity.

Authors:  Veronica R Placencio; Atsuhiko Ichimura; Toshio Miyata; Yves A DeClerck
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

6.  Noise Power Characteristics of a Micro-Computed Tomography System.

Authors:  Muhammad U Ghani; Liqiang Ren; Molly Wong; Yuhua Li; Bin Zheng; Xiujiang John Rong; Kai Yang; Hong Liu
Journal:  J Comput Assist Tomogr       Date:  2017-01       Impact factor: 1.826

7.  Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.

Authors:  Tasnim Ara; Liping Song; Hiroyuki Shimada; Nino Keshelava; Heidi V Russell; Leonid S Metelitsa; Susan G Groshen; Robert C Seeger; Yves A DeClerck
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

Review 8.  Musculoskeletal molecular imaging: a comprehensive overview.

Authors:  Marie K Reumann; Mitchell C Weiser; Philipp Mayer-Kuckuk
Journal:  Trends Biotechnol       Date:  2010-01-04       Impact factor: 19.536

9.  In Vivo MicroCT Monitoring of Osteomyelitis in a Rat Model.

Authors:  Vincent A Stadelmann; Inga Potapova; Karin Camenisch; Dirk Nehrbass; R Geoff Richards; T Fintan Moriarty
Journal:  Biomed Res Int       Date:  2015-04-29       Impact factor: 3.411

10.  Targeting Survivin Enhances Chemosensitivity in Retinoblastoma Cells and Orthotopic Tumors.

Authors:  Angela Ferrario; Marian Luna; Natalie Rucker; Sam Wong; Ariel Lederman; Jonathan Kim; Charles Gomer
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.